{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:30:11Z","timestamp":1791941411813,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T00:00:00Z","timestamp":1502841600000},"content-version":"vor","delay-in-days":380,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.immuni.2016.07.011","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T19:47:18Z","timestamp":1470772038000},"page":"389-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":685,"title":["Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis"],"prefix":"10.1016","volume":"45","author":[{"given":"Andrea","family":"Schietinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varintra E.","family":"Krisnawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edison Y.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Delrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Basom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk G.","family":"Brockstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue E.","family":"Knoblaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter J.","family":"H\u00e4mmerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd D.","family":"Schell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalio","family":"Garbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2016.07.011_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2016.07.011_bib2","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1172\/JCI46102","article-title":"Exhaustion of tumor-specific CD8+ T\u00a0cells in metastases from melanoma patients","volume":"121","author":"Baitsch","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2016.07.011_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T\u00a0cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2016.07.011_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T\u00a0cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib5","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2016.07.011_bib6","doi-asserted-by":"crossref","first-page":"13832","DOI":"10.1073\/pnas.0406035101","article-title":"Listeria-based cancer vaccines that segregate immunogenicity from toxicity","volume":"101","author":"Brockstedt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2016.07.011_bib7","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1038\/oncsis.2012.27","article-title":"Comparative analysis of SV40 17kT and LT function in\u00a0vivo demonstrates that LT\u2019s C-terminus re-programs hepatic gene expression and is necessary for tumorigenesis in the liver","volume":"1","author":"Comerford","year":"2012","journal-title":"Oncogenesis"},{"key":"10.1016\/j.immuni.2016.07.011_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-065X.2010.00926.x","article-title":"Generation of effector CD8+ T\u00a0cells and their conversion to memory T\u00a0cells","volume":"236","author":"Cui","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2016.07.011_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/030098589303000203","article-title":"Histologic characterization of hepatic carcinogenesis in transgenic mice expressing SV40 T-antigens","volume":"30","author":"Cullen","year":"1993","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.immuni.2016.07.011_bib11","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.4049\/jimmunol.175.11.7093","article-title":"Cutting edge: CD8+CD122+ regulatory T\u00a0cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T\u00a0cells","volume":"175","author":"Endharti","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib13","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.15252\/embj.201490786","article-title":"Molecular profiling of CD8 T\u00a0cells in autochthonous melanoma identifies Maf as driver of exhaustion","volume":"34","author":"Giordano","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.immuni.2016.07.011_bib14","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI73639","article-title":"PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors","volume":"124","author":"Gros","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2016.07.011_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2016.07.011_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nature06868","article-title":"Vascular normalization in Rgs5-deficient tumours promotes immune destruction","volume":"453","author":"Hamzah","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2016.07.011_bib17","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/2201352a0","article-title":"Cellular and humoral immunity to different types of human neoplasms","volume":"220","author":"Hellstr\u00f6m","year":"1968","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2016.07.011_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2016.07.011_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.immuni.2016.07.011_bib20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri3307","article-title":"Transcriptional control of effector and memory CD8+ T\u00a0cell differentiation","volume":"12","author":"Kaech","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.4161\/onci.21511","article-title":"In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census","volume":"1","author":"Khalili","year":"2012","journal-title":"OncoImmunology"},{"key":"10.1016\/j.immuni.2016.07.011_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1158\/1078-0432.CCR-05-1672","article-title":"Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer","volume":"12","author":"Kubuschok","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2016.07.011_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.2834","article-title":"The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T\u00a0cells","volume":"15","author":"Kurachi","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib24","doi-asserted-by":"crossref","first-page":"16013","DOI":"10.1073\/pnas.0500090102","article-title":"The response of autologous T\u00a0cells to a human melanoma is dominated by mutated neoantigens","volume":"102","author":"Lennerz","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2016.07.011_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nm.3773","article-title":"High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T\u00a0cells in human melanoma","volume":"21","author":"Linnemann","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2016.07.011_bib26","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.4049\/jimmunol.1202830","article-title":"Mutated PPP1R3B is recognized by T\u00a0cells used to treat a melanoma patient who experienced a durable complete tumor regression","volume":"190","author":"Lu","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib27","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.4049\/jimmunol.167.10.5620","article-title":"Role of CD28 for the generation and expansion of antigen-specific CD8(+) T lymphocytes during infection with Listeria monocytogenes","volume":"167","author":"Mittr\u00fccker","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2016.07.011_bib29","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.4049\/jimmunol.1401572","article-title":"The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity","volume":"193","author":"Ostrand-Rosenberg","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib30","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1229620","article-title":"Progenitor and terminal subsets of CD8+ T\u00a0cells cooperate to contain chronic viral infection","volume":"338","author":"Paley","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.immuni.2016.07.011_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coi.2014.01.002","article-title":"Orchestrating immune check-point blockade for cancer immunotherapy in combinations","volume":"27","author":"Perez-Gracia","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2567.2010.03258.x","article-title":"Ribosomal versus non-ribosomal cellular antigens: factors determining efficiency of indirect presentation to CD4+ T\u00a0cells","volume":"130","author":"Philip","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.immuni.2016.07.011_bib33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2010-12-325035","article-title":"The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed","volume":"118","author":"Popovic","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2016.07.011_bib34","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.2232","article-title":"Transcriptional analysis of HIV-specific CD8+ T\u00a0cells shows that PD-1 inhibits T\u00a0cell function by upregulating BATF","volume":"16","author":"Quigley","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2016.07.011_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.immuni.2016.07.011_bib36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.183.3.1185","article-title":"A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes","volume":"183","author":"Robbins","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2016.07.011_bib37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nm.3161","article-title":"Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T\u00a0cells","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2016.07.011_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2012.08.005","article-title":"Basic principles of tumor-associated regulatory T\u00a0cell biology","volume":"34","author":"Savage","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","article-title":"Tolerance and exhaustion: defining mechanisms of T\u00a0cell dysfunction","volume":"35","author":"Schietinger","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.smim.2008.07.001","article-title":"Specificity in cancer immunotherapy","volume":"20","author":"Schietinger","year":"2008","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib41","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1126\/science.1214277","article-title":"Rescued tolerant CD8 T\u00a0cells are preprogrammed to reestablish the tolerant state","volume":"335","author":"Schietinger","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.immuni.2016.07.011_bib42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2009.06.019","article-title":"A role for the transcriptional repressor Blimp-1 in CD8(+) T\u00a0cell exhaustion during chronic viral infection","volume":"31","author":"Shin","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2016.07.011_bib43","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/CJI.0b013e3181b0b125","article-title":"Priming and activation of human ovarian and breast cancer-specific CD8+ T\u00a0cells by\u00a0polyvalent Listeria monocytogenes-based vaccines","volume":"32","author":"Sinnathamby","year":"2009","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.immuni.2016.07.011_bib44","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2016.07.011_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2009.01.011","article-title":"Tumor agonist peptides break tolerance and elicit effective CTL responses in an inducible mouse model of hepatocellular carcinoma","volume":"123","author":"Stahl","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.immuni.2016.07.011_bib46","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4049\/jimmunol.171.2.697","article-title":"In\u00a0vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T\u00a0cell effector function in SV40\u00a0T antigen transgenic mice","volume":"171","author":"Staveley-O\u2019Carroll","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib47","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.4049\/jimmunol.174.8.4639","article-title":"Signals from CD28 induce stable epigenetic modification of the IL-2 promoter","volume":"174","author":"Thomas","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2016.07.011_bib48","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2016.07.011_bib49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.1251102","article-title":"Cancer immunotherapy based on mutation-specific CD4+ T\u00a0cells in a patient with epithelial cancer","volume":"344","author":"Tran","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.immuni.2016.07.011_bib50","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1200\/JCO.2012.47.7521","article-title":"Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma","volume":"31","author":"van Rooij","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.immuni.2016.07.011_bib51","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature04431","article-title":"The Polycomb group protein EZH2 directly controls DNA methylation","volume":"439","author":"Vir\u00e9","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2016.07.011_bib52","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T\u00a0cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2016.07.011_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature03954","article-title":"Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance","volume":"437","author":"Willimsky","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2016.07.011_bib54","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/515496a","article-title":"Cancer: Antitumour immunity gets a boost","volume":"515","author":"Wolchok","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2016.07.011_bib55","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.7652577","article-title":"A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma","volume":"269","author":"W\u00f6lfel","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.immuni.2016.07.011_bib56","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2011.06.015","article-title":"Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T\u00a0cells","volume":"35","author":"Youngblood","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2016.07.011_bib57","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1158\/0008-5472.CAN-03-3066","article-title":"Effector function of human tumor-specific CD8 T\u00a0cells in melanoma lesions: a state of local functional tolerance","volume":"64","author":"Zippelius","year":"2004","journal-title":"Cancer Res."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761316302849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761316302849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T05:54:04Z","timestamp":1536472444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761316302849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1074761316302849"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2016.07.011","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2016.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}